What medications are recommended for a patient with post-traumatic stress disorder (PTSD) and depression, considering potential substance abuse history?

Treatment of PTSD and Depression with Substance Abuse History

For patients with PTSD and depression, especially those with substance abuse history, trauma-focused psychotherapy (Prolonged Exposure, Cognitive Processing Therapy, or EMDR) should be the first-line treatment, with SSRIs (sertraline, paroxetine, or fluoxetine) reserved for cases where psychotherapy is unavailable, refused, or insufficient, while benzodiazepines must be absolutely avoided due to evidence of harm and high abuse potential. 1, 2

First-Line Treatment: Trauma-Focused Psychotherapy

Trauma-focused psychotherapy is the primary intervention and should be offered first, as it demonstrates superior durability with 40-87% of patients no longer meeting PTSD criteria after 9-15 sessions. 1, 3 The three evidence-based options with strongest support are:

• Prolonged Exposure (PE) 1, 3
• Cognitive Processing Therapy (CPT) 1, 3
• Eye Movement Desensitization and Reprocessing (EMDR) 1, 3

All three therapies show equivalent efficacy regardless of trauma type, childhood abuse history, or comorbidities including substance use history. 1, 2 Critically, relapse rates are substantially lower after completing CBT compared to medication discontinuation (26-52% relapse with sertraline discontinuation versus lower rates post-CBT). 1, 2

When psychotherapy is geographically inaccessible, secure video teleconferencing can effectively deliver trauma-focused therapy with equivalent outcomes. 1, 3

When to Add Pharmacotherapy

Medication should be considered in these specific scenarios: 2, 3

• Psychotherapy is unavailable or inaccessible
• Patient refuses or cannot engage in psychotherapy
• Residual symptoms persist after completing psychotherapy
• Patient strongly prefers medication

Recommended Medications

SSRIs as First-Line Pharmacotherapy

The only appropriate pharmacological options in patients with substance use history are SSRIs, specifically: 2, 4

• Sertraline (FDA-approved for PTSD) 5, 4
• Paroxetine (FDA-approved for PTSD) 5, 4
• Fluoxetine 5, 4

SSRIs show 53-85% of participants classified as treatment responders in controlled trials and have a favorable adverse effect profile. 2, 5 Continue SSRI treatment long-term (at least 6-12 months after symptom remission) as discontinuation leads to high relapse rates of 26-52% when shifted to placebo compared to only 5-16% maintained on medication. 1, 4

Addressing Depression Symptoms

When depression and anxiety co-occur with PTSD, prioritize treating depressive symptoms first, or use a unified protocol combining CBT treatments for both conditions. 3 Antidepressants should not be used for initial treatment of mild depressive episodes, but tricyclic antidepressants or fluoxetine should be considered in moderate to severe depressive episodes. 6

Adjunctive Medications for Specific Symptoms

For PTSD-related nightmares and insomnia, prazosin is recommended with Level A evidence: 1, 4, 7

• Initial dose: 1 mg at bedtime
• Increase 1-2 mg every few days
• Average effective dose: 3 mg (range 1-13 mg)
• Monitor for orthostatic hypotension 1

Critical Medications to AVOID

Benzodiazepines Are Absolutely Contraindicated

Benzodiazepines must be avoided in patients with substance use history due to high abuse potential and evidence showing they worsen PTSD outcomes. 1, 2 Evidence demonstrates that 63% of patients receiving benzodiazepines (including alprazolam and clonazepam) developed PTSD at 6 months compared to only 23% receiving placebo. 1, 2

The 2023 VA/DoD guideline strongly recommends AGAINST benzodiazepines for PTSD treatment. 1

Other Medications to Avoid

• Bupropion was ineffective in PTSD in open-label studies 5
• Psychological debriefing (single-session intervention within 24-72 hours post-trauma) should not be used as it may be harmful 6, 1
• Beta blockers have no evidence supporting their use as monotherapy for established PTSD 1

Treatment Algorithm

1. Initiate trauma-focused psychotherapy (PE, CPT, or EMDR) as first-line treatment 1, 3
2. If psychotherapy unavailable or insufficient, add SSRI (sertraline, paroxetine, or fluoxetine) 2, 4
3. Assess treatment response at 4 and 8 weeks using standardized validated instruments 3
4. If inadequate response after 8 weeks with good adherence: 3
   • Add psychological intervention to pharmacotherapy, OR
   • Switch to different SSRI, OR
   • Add pharmacotherapy to psychotherapy
5. For persistent nightmares, add prazosin 1, 4
6. Continue SSRI for 6-12 months minimum after symptom remission before considering discontinuation 1, 4

Common Pitfalls to Avoid

Do not delay trauma-focused treatment even in complex presentations with multiple traumas, substance use history, or severe comorbidities. 1, 3 Prolonged stabilization phases before trauma-focused therapy can be demoralizing and inadvertently communicate that patients cannot handle their traumatic memories. 3

Do not use benzodiazepines despite patient requests for anxiety relief, as they worsen long-term PTSD outcomes and carry high abuse potential in patients with substance use history. 1, 2

Combination therapy (trauma-focused psychotherapy plus SSRI) is the optimal strategy for severe or treatment-resistant cases, as psychotherapy provides more durable benefits and allows for eventual medication discontinuation with lower relapse risk. 3